| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |